{"entity":{"type":"insider","cik":"0001653082","url":"/insider/0001653082","json_url":"/insider/0001653082.json","name":"Heier Jeffrey S.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":10,"first":"2019-03-18","last":"2026-05-28","span_basis":"filed_date"},"name_variants":[{"name":"Heier Jeffrey S.","source":"filing","n_filings":10,"first_seen":"2019-03-18","last_seen":"2026-05-28"}],"transactions":[{"id":6132112,"accession":"0001104659-26-067481","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-067481","line_url":"/filing/0001104659-26-067481#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001653082","owner_name":"Heier Jeffrey S.","owner_display_name":"Heier Jeffrey S.","owner_url":"/insider/0001653082","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3018.0,"shares_display":"3,018","price_per_share":8.2,"price_display":"8.20","price_state":"stated","total_value":24747.6,"total_display":"24,747.60","total_whole":"24,748","shares_owned_after":320350.0,"shares_owned_after_display":"320,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-26","filed_date":"2026-05-28","scope":"insider"},{"id":5833323,"accession":"0001104659-26-019803","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-019803","line_url":"/filing/0001104659-26-019803#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001653082","owner_name":"Heier Jeffrey S.","owner_display_name":"Heier Jeffrey S.","owner_url":"/insider/0001653082","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3057.0,"shares_display":"3,057","price_per_share":8.28,"price_display":"8.28","price_state":"stated","total_value":25311.96,"total_display":"25,311.96","total_whole":"25,312","shares_owned_after":323368.0,"shares_owned_after_display":"323,368","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-23","filed_date":"2026-02-25","scope":"insider"},{"id":5129677,"accession":"0001104659-25-116420","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-116420","line_url":"/filing/0001104659-25-116420#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001653082","owner_name":"Heier Jeffrey S.","owner_display_name":"Heier Jeffrey S.","owner_url":"/insider/0001653082","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3469.0,"shares_display":"3,469","price_per_share":12.04,"price_display":"12.04","price_state":"stated","total_value":41766.76,"total_display":"41,766.76","total_whole":"41,767","shares_owned_after":245940.0,"shares_owned_after_display":"245,940","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-24","filed_date":"2025-11-26","scope":"insider"},{"id":4199353,"accession":"0001104659-25-097163","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-097163","line_url":"/filing/0001104659-25-097163#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001653082","owner_name":"Heier Jeffrey S.","owner_display_name":"Heier Jeffrey S.","owner_url":"/insider/0001653082","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10502.0,"shares_display":"10,502","price_per_share":11.04,"price_display":"11.04","price_state":"stated","total_value":115942.08,"total_display":"115,942.08","total_whole":"115,942","shares_owned_after":249409.0,"shares_owned_after_display":"249,409","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-06","scope":"insider"},{"id":4923174,"accession":"0001104659-25-084115","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-084115","line_url":"/filing/0001104659-25-084115#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001653082","owner_name":"Heier Jeffrey S.","owner_display_name":"Heier Jeffrey S.","owner_url":"/insider/0001653082","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3063.0,"shares_display":"3,063","price_per_share":12.04,"price_display":"12.04","price_state":"stated","total_value":36878.52,"total_display":"36,878.52","total_whole":"36,879","shares_owned_after":259911.0,"shares_owned_after_display":"259,911","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-25","filed_date":"2025-08-27","scope":"insider"},{"id":4168194,"accession":"0001104659-25-053090","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-053090","line_url":"/filing/0001104659-25-053090#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001653082","owner_name":"Heier Jeffrey S.","owner_display_name":"Heier Jeffrey S.","owner_url":"/insider/0001653082","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3024.0,"shares_display":"3,024","price_per_share":7.18,"price_display":"7.18","price_state":"stated","total_value":21712.32,"total_display":"21,712.32","total_whole":"21,712","shares_owned_after":262974.0,"shares_owned_after_display":"262,974","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-23","filed_date":"2025-05-27","scope":"insider"},{"id":4347752,"accession":"0001104659-25-017567","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-017567","line_url":"/filing/0001104659-25-017567#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001653082","owner_name":"Heier Jeffrey S.","owner_display_name":"Heier Jeffrey S.","owner_url":"/insider/0001653082","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3061.0,"shares_display":"3,061","price_per_share":6.87,"price_display":"6.87","price_state":"stated","total_value":21029.07,"total_display":"21,029.07","total_whole":"21,029","shares_owned_after":265998.0,"shares_owned_after_display":"265,998","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-24","filed_date":"2025-02-26","scope":"insider"},{"id":3268833,"accession":"0001104659-24-123417","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-123417","line_url":"/filing/0001104659-24-123417#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001653082","owner_name":"Heier Jeffrey S.","owner_display_name":"Heier Jeffrey S.","owner_url":"/insider/0001653082","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2948.0,"shares_display":"2,948","price_per_share":9.01,"price_display":"9.01","price_state":"stated","total_value":26561.48,"total_display":"26,561.48","total_whole":"26,561","shares_owned_after":269059.0,"shares_owned_after_display":"269,059","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-25","filed_date":"2024-11-27","scope":"insider"},{"id":6101738,"accession":"0001104659-22-061314","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-061314","line_url":"/filing/0001104659-22-061314#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001653082","owner_name":"Heier Jeffrey S.","owner_display_name":"Heier Jeffrey S.","owner_url":"/insider/0001653082","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":3.05,"price_display":"3.05","price_state":"stated","total_value":45750.0,"total_display":"45,750.00","total_whole":"45,750","shares_owned_after":39000.0,"shares_owned_after_display":"39,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-12","filed_date":"2022-05-16","scope":"insider"},{"id":7912605,"accession":"0001104659-19-015692","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-015692","line_url":"/filing/0001104659-19-015692#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001653082","owner_name":"Heier Jeffrey S.","owner_display_name":"Heier Jeffrey S.","owner_url":"/insider/0001653082","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":24000.0,"shares_display":"24,000","price_per_share":4.15,"price_display":"4.15","price_state":"stated","total_value":99600.0,"total_display":"99,600.00","total_whole":"99,600","shares_owned_after":24000.0,"shares_owned_after_display":"24,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-15","filed_date":"2019-03-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001393434","name":"OCULAR THERAPEUTIX, INC","url":"/issuer/0001393434","role":"Director, Officer (Chief Scientific Officer)","n_filings":10,"first_seen":"2019-03-18","last_seen":"2026-05-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001653082","retrieved_at":"2026-08-24T23:33:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}